Company news
Liaoning Chengda Biotechnology Co. Ltd. Class A (SSE:688739) news
Liaoning Chengda Biotechnology Co. Ltd. Class A news releases on 6ix. Latest, Mar 20, 2025: Announcement on Voluntary Disclosure of the Entry of the Human…
Press releases — page 2
Announcement on Voluntary Disclosure of the Entry of the Human Papillomavirus15-valent Vaccine (Escherichia Coli) into Phase II Clinical Trials
March 19, 2025
First Indicative Announcement on Tender Offer for Company Shares by Shaoguan Gaoteng Enterprise Management Co., Ltd.
March 13, 2025
Indicative Announcement on Completion of Change of Actual Controller
March 2, 2025
Announcement on Preliminary Earnings Estimate for 2024
February 25, 2025